Immuneering Corporation (IMRX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 64
-0.14
-2.9289%
$
189.14M Market Cap
- P/E Ratio
- Div Yield
1.45M Volume
-1.89 Eps
$ 4.78
Previous Close 
Want to track IMRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immuneering Corporation (IMRX) Statistics
Valuation metrics
Market Cap 189.14M
Enterprise value 3.85B
Trailing P/E (ttm) -3.97
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) -
Price/Book (mrq) 0
Enterprise Value/Revenue -
Enterprise Value/EBITDA -65.44
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.43M
Average volume (90 days) 1.51M
Price summary
52-Week low 2.9
52-Week high 10.08
Beta -
50-Day moving average 4.38
200-Day moving average 5.19
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0%
Return on equity -0%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 32.45%
Book value per share (mrq) 4,692.33
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
